Moderna burnishes its PhIII-ready Covid-19 vaccine with promising mouse data — which suggest one dose might be enough after all
Moderna and the NIH didn’t wait for animal data to begin testing its mRNA vaccine candidate in patients. But on the same day they unveiled …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
